Skip to main content
. 2012 Nov 8;12:385. doi: 10.1186/1472-6963-12-385

Figure 3.

Figure 3

Tornado diagram representing the net health benefit (QALYs, WTP=$11,034) determined by a one-way sensitivity analysis of combination therapy (ADV+LMV) vs. no treatment for LAM-resistant HBeAg-positive (A) and HBeAg-negative (B) chronic hepatitis B. The vertical line represents the base-case value for the net health benefit under WTP=$11,034.